<DOC>
	<DOCNO>NCT00424333</DOCNO>
	<brief_summary>To determine subject Type 1 Diabetes Mellitus : 1 . Whether glycemic control achieve least effectively ) intensive insulin regimen involve pre-meal inhaled insulin plus twice daily subcutaneous NPH insulin b ) intensive subcutaneous insulin regimen involve pre-meal regular insulin plus twice daily NPH , give 4 injection per day . The treatment regimens differ route delivery short act insulin . 2 . The toleration safety inhale insulin therapy effect 6months , , measure pulmonary function .</brief_summary>
	<brief_title>Six Month Clinical Trial Assessing Efficacy Safety Inhaled Insulin Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 Diabetes 1 year Stable insulin regimen least 2 injection per day Any smoking within last 6 month . Smoking permitted time study . Subjects insulin pump 2 month prior screen . Subjects poorlycontrolled asthma , clinically significant chronic obstructive pulmonary disease , significant respiratory disease .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>